These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

46 related items for PubMed ID: 7695954

  • 1. [The midterm inefficacy of 2 different dosages of chlorthalidone (50 and 25 mg/day) in the regression of left ventricular mass in arterial hypertension].
    González-Juanatey JR, Pose Reino A, Amaro Cendón A, García Acuña JM, Castelo Fuentes V, Calvo Gómez C, de la Peña MG.
    Rev Port Cardiol; 1995 Jan; 14(1):43-50. PubMed ID: 7695954
    [Abstract] [Full Text] [Related]

  • 2. [Regression of left ventricular mass in arterial hypertension. Efficacy of 3 different treatment protocols].
    González-Juanatey JR, Amaro Cendón A, Calvo Gómez C, Vega Fernández M, García Acuña JM, Virgós Lamela A, Gil de la Peña M.
    Med Clin (Barc); 1992 Mar 21; 98(11):401-4. PubMed ID: 1533259
    [Abstract] [Full Text] [Related]

  • 3. Improvement of diastolic function after regression of left ventricular hypertrophy.
    Teniente-Valente R, Solorio S, Vargas-Salado E, Aguirre-Vázquez C, Hernández-González MA, Olvera-Lopez JA, Rodríguez-Mariscal L, Luna-Ruiz MA, Guillén Contreras JM, Murillo Ortiz BO.
    Arch Cardiol Mex; 2008 Mar 21; 78(4):392-9. PubMed ID: 19205547
    [Abstract] [Full Text] [Related]

  • 4. Effects of antihypertensive therapy on left atrial function.
    Dernellis JM, Vyssoulis GP, Zacharoulis AA, Toutouzas PK.
    J Hum Hypertens; 1996 Dec 21; 10(12):789-94. PubMed ID: 9140783
    [Abstract] [Full Text] [Related]

  • 5. Effects of four antihypertensive monotherapies on cardiac mass and function in hypertensive patients with left ventricular hypertrophy: randomized prospective study.
    Rakić D, Rumboldt Z, Bagatin J, Polić S.
    Croat Med J; 2002 Dec 21; 43(6):672-9. PubMed ID: 12476475
    [Abstract] [Full Text] [Related]

  • 6. Impact of myocardial diastolic dysfunction on coronary flow reserve in hypertensive patients with left ventricular hypertrophy.
    Galderisi M, Cicala S, De Simone L, Caso P, Petrocelli A, Pietropaolo L, Celentano A, Mininni N, de Divitiis O.
    Ital Heart J; 2001 Sep 21; 2(9):677-84. PubMed ID: 11666096
    [Abstract] [Full Text] [Related]

  • 7. [Effect of treatment with chlorthalidone on reduction of left ventricular mass in patients with systemic arterial hypertension].
    Ramires JA, Mansur Ade P, Oigman W, Francischetti E, César LA, Marcondes M, da Luz PL, Pileggi F.
    Arq Bras Cardiol; 1993 Jun 21; 60(6):433-5. PubMed ID: 8279986
    [Abstract] [Full Text] [Related]

  • 8. Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan.
    Avanza AC, El Aouar LM, Mill JG.
    Arq Bras Cardiol; 2000 Feb 21; 74(2):103-17. PubMed ID: 10904284
    [Abstract] [Full Text] [Related]

  • 9. Beta2-adrenergic receptor polymorphisms and treatment-induced regression of left ventricular hypertrophy in hypertension.
    Iaccarino G, Izzo R, Trimarco V, Cipolletta E, Lanni F, Sorriento D, Iovino GL, Rozza F, De Luca N, Priante O, Di Renzo G, Trimarco B.
    Clin Pharmacol Ther; 2006 Dec 21; 80(6):633-45. PubMed ID: 17178264
    [Abstract] [Full Text] [Related]

  • 10. [The regression of left ventricular hypertrophy and improvement in diastolic filling during antihypertensive therapy with cilazapril].
    Sabatini D, Fazio S, Cittadini A, Biondi B, Lucariello A, Picano T, Saccà L.
    Cardiologia; 1993 Jun 21; 38(6):377-81. PubMed ID: 8402747
    [Abstract] [Full Text] [Related]

  • 11. Persistence of left ventricular hypertrophy is a stronger indicator of cardiovascular events than baseline left ventricular mass or systolic performance: 10 years of follow-up.
    Muiesan ML, Salvetti M, Rizzoni D, Monteduro C, Castellano M, Agabiti-Rosei E.
    J Hypertens Suppl; 1996 Dec 21; 14(5):S43-9. PubMed ID: 9120684
    [Abstract] [Full Text] [Related]

  • 12. [Effect of 3 hypertensive++ agents on ventricular geometry and function].
    Gómez Pajuelo C, Gómez Sánchez MA, Marín Ruiz R, Lombera Romero F, Sanz Julve M, Tascón Pérez J, Sáenz de la Calzada C.
    Med Clin (Barc); 1995 Mar 11; 104(9):334-8. PubMed ID: 7731301
    [Abstract] [Full Text] [Related]

  • 13. Differential effects of once-daily antihypertensive drugs on blood pressure, left ventricular mass and sympathetic activity: Nifedipine-GITS versus felodipine-ER versus enalapril.
    Leenen FH, Myers MG, Joyner CD, Toal CB.
    Can J Cardiol; 2002 Dec 11; 18(12):1285-93. PubMed ID: 12518180
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V, Devereux RB.
    Minerva Cardioangiol; 2002 Jun 11; 50(3):169-74. PubMed ID: 12107398
    [Abstract] [Full Text] [Related]

  • 15. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.
    Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Dahlof B, Losartan Intervention for Endpoint reduction in hypertension Study Investigations.
    Circulation; 2003 Aug 12; 108(6):684-90. PubMed ID: 12885747
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [The effect of nifedipine in hypertensive cardiopathy. An echocardiographic and electrocardiographic study].
    Sau F, Seguro C, Lai C, Onnis E, Orani E, Soro A, Leo MR, Cherchi A.
    Cardiologia; 1993 Jun 12; 38(6):369-76. PubMed ID: 8402746
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.